Do you know how to categorize Covid-19 Symptoms?

Stage 1

Testing Positive Without Any Symptoms

Only RT-PCR is positive

Stage 2

Testing Positive With Only Mild Symptoms

Symptoms includes sore throat, dry cough or fever

Stage 3

Developing some form of pneumonia

This includes vomiting, diarrhea, abdominal pain, myalgia, loss of smell/taste. Signs of increased work of breathing, increased respiratory rate, but no hypoxemia.

Stage 4

Breathing difficulties and requiring oxygen support

  • CNS Affect: Lethargy, decreased level of consciousness, seizure
  • GI effects: Dehydration, difficulty feeding, raised liver enzymes
  • Myocardial effect: Raised Creatinine Kinase, Troponin

Stage 5

Needing to be intubated and put on a ventilator

    Critically ill with multiple organ involvement.
  • Respiratory failure requiring mechanical ventilation
  • Persistent hypoxemia
  • Septic Shock
  • Organ failure

Retrieved From

What is Lung Shield Program?

Lung Shield ‘Program’ provides clients with compassionate use of cellular therapy coverage for post COVID-19 Lung Infection Recovery.

In support of the national vaccination program, all clients of Lung Shield will also be provided a complimentary post COVID-19 vaccine complication cover and accidental death benefits.

Cellular therapy is clinically proven to be effective in the field of regenerative medicine and holds promising potential in treating lung damage inflicted by Covid-19.

Lung Shield only used Mesenchymal stem cells produced under current Good Manufacturing Practice (cGMP).

Lung Shield Program Benefits

Get protected with stem cell therapy and insurance coverage in case of Covid 19 lung damage

Cellular Coverage

  • Cellular therapy for lung damage caused by post Covid-19 infection (Up to 40 million Mesenchymal Stem Cells)
  • Pre cellular therapy health screening
  • Lung function test

Personal Accident Insurance

  • Accidental death RM5,000
  • Accidental permanent disablement RM5,000

Post Covid-19 Vaccination Coverage

  • Daily Hospital Income Benefit at RM400 per day up to RM5,600
  • A lump sum benefit of RM4,000 for Intensive Care Unit (ICU) admission
  • Bereavement expense benefit up to RM10,000
  • Accidental death RM10,000

Covid Screening Included

  • Free initial RT-PCR Test
  • Free Functional Neutralising Total Antibody Test (Check your immunity levels towards Covid-19!)
  • *Limited to 2 persons per family package

E&OE and T&Cs apply

Download Brochure

What is Cellular Therapy?

Cellular therapy have the ability to differentiate, repair, restore, replace and regenerate cells. It can provide new cells as the body grows and replace cells that are damaged or lost. Hence, widely known as regenerative medicine.

Is it safe?

Cellular Therapy is less immunogenic. It lowers the risks of rejection by the individual’s immune system and complications when transplanted.

Homing Ability

Cellular Therapy possesses a unique homing ability. Once transplanted, the cells are naturally directed to the damaged tissues which are in need of repair and replacement.

How Does Stem Cell Therapy Work?

Repair & Regenerate damaged cells
Anti-inflammatory Actions
Reduces Oxidative Stress
Tissue Repair/Renovation
Antimicrobial Action

Is it an effective treatment for post Covid-19 lung damage?

Cellular therapy possesses immunomodulatory properties. They have been shown to reduce inflammatory markers in several studies. Recent Clinical Trials show that cellular therapy reduces the risk of complications and death in SARS-CoV-2 infected patients. They help to improve the microenvironment, promote neovascularization, inhibit pulmonary fibrosis and enhance tissue repair capabilities.

Is it an approved treatment?

Generally all stem cell products require FDA approval. Currently, the only stem cell products that are FDA-approved for use in the United States consist of blood forming stem cells also known as (hematopoietic progenitor cells) that are derived from the umbilical cord blood. These products are approved for use in patients with disorders that affect the production of blood.
In April 2020, the U.S. Food and Drug Administration (FDA) authorized a clinical trial exploratory efficacy study that used umbilical cord-derived MSCs for prevention of the life-threatening lung inflammation in COVID-19 patients.
Stem cells should only be used in FDA-approved clinical trials, expanded access program, or an Emergency Investigation New Drug application and for compassionate use.

Underwriters and

Make an Appointment Now!